Andy Chevigné and his crew, RTI-5152-12 is postulated to enhance the amounts of opioid peptides that bind to classical opioid receptors during the Mind, leading to heightened painkilling activity. The LIH-RTI study groups founded a collaboration agreement and submitted a joint patent soft